Back to top

Capricor Therapeutics Updates on Duchenne Treatment Progress

Capricor Therapeutics (CAPR) has provided an update. The Company has recently shared a presentation on the progress of its CAP-1002 treatment for D...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Capricor Therapeutics, Inc. (CAPR)